Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 2 (2005), Issue 2 (February)

1. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
   Magn Reson Med, 53(2): 256-66. [Abstract] [Full-text]
2. Echo time optimization for linear combination myelin imaging.
   Magn Reson Med, 53(2): 398-407. [Abstract] [Full-text]
3. Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis.
   J Lipid Res, 46(2): 191-5. [Abstract] [Full-text]
4. Evaluation of accuracy in MS lesion volumetry using realistic lesion phantoms.
   Acad Radiol, 12(1): 17-24. [Abstract] [Full-text]
5. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis?
   Mol Cell Neurosci, 28(2): 390-401. [Abstract] [Full-text]
6. Multiple sclerosis: long-term remission after a high dose of cyclophosphamide.
   Acta Neurol Scand, 111(3): 195-8. [Abstract] [Full-text]
7. Low dose naltrexone therapy in multiple sclerosis.
   Med Hypotheses, 64(4): 721-4. [Abstract] [Full-text]
8. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
   Med Hypotheses, 64(4): 669-77. [Abstract] [Full-text]
9. Association of fatigue and brain atrophy in multiple sclerosis.
   J Neurol Sci, 228(2): 161-6. [Abstract] [Full-text]
10. Somatosensory-evoked cortical potential during attacks of paroxysmal dysesthesia in multiple sclerosis.
    Eur J Neurol, 12(3): 233-4. [Abstract] [Full-text]
11. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients.
    Eur J Neurol, 12(3): 208-11. [Abstract] [Full-text]
12. IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis.
    Eur J Neurol, 12(3): 171-5. [Abstract] [Full-text]
13. No evidence of pancreatic autoimmunity among patients with multiple sclerosis.
    Ann N Y Acad Sci, 1037: 133-7. [Abstract] [Full-text]
14. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo.
    Exp Neurol, 192(1): 125-33. [Abstract] [Full-text]
15. Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis.
    J Clin Endocrinol Metab, 90(2): 734-40. [Abstract] [Full-text]
16. Skeletal muscle characteristics of people with multiple sclerosis.
    Arch Phys Med Rehabil, 86(2): 224-9. [Abstract] [Full-text]
17. Within session practice effects on the PASAT in clients with multiple sclerosis.
    Arch Clin Neuropsychol, 20(2): 145-52. [Abstract] [Full-text]
18. Astrocytoma-like multiple sclerosis.
    Clin Neurol Neurosurg, 107(2): 152-7. [Abstract] [Full-text]
19. The bifid visual evoked potential-normal variant or a sign of demyelination?
    Clin Neurol Neurosurg, 107(2): 113-6. [Abstract] [Full-text]
20. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
    Arch Neurol, 62(2): 277-80. [Abstract] [Full-text]
21. Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
    Arch Neurol, 62(2): 258-64. [Abstract] [Full-text]
22. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
    J Neuroimmunol, 160(1): 195-203. [Abstract] [Full-text]
23. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
    J Neuroimmunol, 160(1): 122-34. [Abstract] [Full-text]
24. Inflammation stimulates remyelination in areas of chronic demyelination.
    Brain, 128: 528-39. [Abstract] [Full-text]
25. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.
    Brain, 128: 516-27. [Abstract] [Full-text]
26. Effects of peripheral cooling on intention tremor in multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 76(3): 373-9. [Abstract] [Full-text]
27. Infectious causes of multiple sclerosis.
    Lancet Neurol, 4(3): 195-202. [Abstract] [Full-text]
28. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    J Neurol, 252(2): 146-50. [Abstract] [Full-text]
29. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study.
    Neurol Sci, 25(6): 307-10. [Abstract] [Full-text]
30. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI.
    Neurology, 64(4): 631-5. [Abstract] [Full-text]
31. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Neurology, 64(4): 621-30. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.